Workflow
ParaZero Secures New European Order for SafeAir M4 Systems, Expanding Presence in Innovative Drone Market
GlobeNewswire· 2025-05-13 12:32
TEL AVIV, Israel, May 13, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aircrafts and defense counter-UAS systems, today announced a follow-on purchase order for its innovative SafeAir™ M4 parachute recovery system from a prominent drone technology partner in Europe. This order reflects ParaZero’s growing traction in Europe’s dynamic drone market, a hub for advanced unmanned aerial syst ...
Helport AI Launches Helport Remote to Redefine Global Contact Center Management
GlobeNewswire· 2025-05-13 12:31
AI-Powered Workforce Monitoring Tool Developed for Large-Scale, Global Operations Targets Rapidly Expanding Remote Customer Service Industry New Offering Pioneers Intelligent Time Management, Video Monitoring, and Performance Insights Across Borders SINGAPORE and MANILA, Philippines and SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI) (“Helport AI” or the “Company”), an AI technology company serving enterprise clients with intelligent customer communication software and services ...
Consolidated Water Receives Key Approval for $204 Million Seawater Desalination Plant Project in Hawaii
GlobeNewswire· 2025-05-13 12:31
GEORGE TOWN, Cayman Islands, May 13, 2025 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported that its wholly owned subsidiary, Kalaeloa Desalco LLC, recently achieved a major milestone for its $204 million project to design, construct, operate and maintain a 1.7 million gallon per day seawater desalination plant in Hawaii. The Honolulu Board of Water Supply, the client for the m ...
Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data
GlobeNewswire News Room· 2025-05-13 12:30
HOUSTON, TX, May 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the reconstitution of its Scientific Advisory Board (SAB) with the appointment of three renowned experts in neurology, neuroimaging, and neurodegenerative diseases. This move reflects Nexalin’s strategic prioritization of Alzheimer’s disease within its broader clinical development pipeline, support ...
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
GlobeNewswire· 2025-05-13 12:30
- BMB-101 demonstrated a complete elimination of drop attacks in the DBA/2 mouse model - - The DBA/2 model is highly predictive of sudden unexpected death in epilepsy (SUDEP) - - Findings highlight BMB-101’s potential to address critical gaps in SUDEP prevention - NEW YORK and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a company focused on developing highly selective 5-HT2 agonists for the treatmen ...
Ozop Energy Solutions, Inc. Issues a Shareholder Update
GlobeNewswire· 2025-05-13 12:30
Warwick, NY, May 13, 2025 (GLOBE NEWSWIRE) -- Ozop Energy Solutions, Inc. (OTC: OZSC) ("Ozop" or the "Company"), a Company focused in the renewable energy sector, today provided an update to its shareholders on recent strategic milestones and upcoming initiatives. With a diverse portfolio of innovative energy solutions, Ozop remains focused on capturing a share of the rapidly growing renewable energy market. Ozop’s wholly owned subsidiary, Automated Room Controls, Inc. (DBA ARC), has made substantial progre ...
Wearable Devices Receives U.S. Patent Notice of Allowance for Hybrid Voice and Gesture Control Innovation
GlobeNewswire· 2025-05-13 12:30
Newly allowed patent extends Wearable Devices’ innovative gesture technology into the domain of voice control YOKNEAM ILLIT, ISRAEL, May 13, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI")-powered touchless sensing wearables, today announced that the United States Patent and Trademark Office has allowed its patent titled “Gesture and Voice-Controlled Interface Device.” This ...
POET Appoints Ghazi Chaoui, PhD, as Senior Vice President – Global Manufacturing and Digital Transformation
GlobeNewswire· 2025-05-13 12:30
Optical Engine Manufacturing Operational at Globetronics in Malaysia and POET Technologies Snd. Bhd. Established as Wholly Owned SubsidiaryTORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- POET Technologies Inc. ("POET" or the "Company") (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced the appointment of Ghazi M. Chaoui, PhD, MBA as its Senior Vice President of Global Manufacturing ...
VERB Beats All Analysts Q1 2025 Financial Performance Estimates
GlobeNewswire News Room· 2025-05-13 12:30
Management Delivers Impressive 80% Revenue Growth Quarter-Over-Quarter Beats All Revenue and EPS Estimates By A Wide Margin Q1 2025 Revenue Exceeds Entire 2024 Annual Revenue Closed $8.5 Million Acquisition Of AI Social Commerce Technology Platform Lyvecom $5 Million Cash Added To Balance Sheet In Non-Dilutive, Non-Convertible, Preferred Stock Deal Zero Debt - Strong Cash Position – Expected To Fund Operations Into 2028 And Beyond Increased Growth Projected For Q2 2025 LAS VEGAS, May 13, 2025 (GLOBE NEWSWIR ...
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
GlobeNewswire· 2025-05-13 12:30
Survival observations in mTNBC patients correlated with increased PD-L1 expression Preliminary evidence suggests leronlimab has potential to turn “cold” tumors “hot” VANCOUVER, Washington, May 13, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced new data suggesting a novel mechanism of action of leronlimab for the treatment of solid tumors ...